Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009;26(7):211-220.

Trends in Clostridium difficile Disease: Epidemiology and Intervention

David J Riddle Dr  1 , Erik R Dubberke Dr  2
Affiliations

Trends in Clostridium difficile Disease: Epidemiology and Intervention

David J Riddle Dr et al. Infect Med. 2009.

Abstract

Clostridium difficile is the most common cause of nosocomial infectious diarrhea. The incidence of C difficile infection (CDI) is increasing in both inpatients and outpatients, and outbreaks caused by a hypervirulent strain of C difficile are resulting in more severe disease. Moreover, community-associated CDI is occurring in persons who lack the traditional risk factors, which include antibiotic use, advanced age, and severe underlying disease. The clinical severity of CDI ranges from a mild, self-limited diarrheal illness to a fulminant, life-threatening colitis. Enzyme-linked immunosorbent assay is the most common laboratory method used for detection of C difficile toxins and can confirm the diagnosis within several hours. The choice of treatment should be based on disease severity. Oral metronidazole is generally regarded as the treatment of choice for mild to moderate CDI, while oral vancomycin is recommended for severe disease. Timely surgical intervention is important in patients who have severe complicated CDI.

Keywords: Clostridium difficile; Pseudomembranous colitis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diagnosis and Treatment of CDI
See this image and copyright information in PMC

References

    1. Hall IC, O’Toole E. Intestinal flora in ew-born infants with a description of a new pathogenic anaerobe, Bacillus difficilis. American Journal of Diseases in Children. 1935;49:390–402.
    1. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med. 1978 Mar 9;298(10):531–534. - PubMed
    1. Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis. 1977 Nov;136(5):701–705. - PubMed
    1. Gursoy S, Guven K, Arikan T, et al. Clostridium difficile infection frequency in patients with nosocomial infections or using antibiotics. Hepatogastroenterology. 2007 Sep;54(78):1720–1724. - PubMed
    1. Barbut F, Corthier G, Charpak Y, et al. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study. Arch Intern Med. 1996 Jul 8;156(13):1449–1454. - PubMed

LinkOut - more resources